• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镁水平与舒张压(DBP)作为动脉瘤性蛛网膜下腔出血(SAH)患者血管痉挛预测指标的研究

Magnesium Levels and Diastolic Blood Pressure (DBP) as a Vasospasm Prediction Metric in Patients With Aneurysmal Subarachnoid Hemorrhage (SAH).

作者信息

Savla Paras, Marino Maxwell A, Marotta Dario A, Brazdzionis James, Farr Saman, Podkovik Stacey, Wiginton James, Tayag Emilio C, Cortez Vladimir, Miulli Dan E

机构信息

Neurosurgery, Riverside University Health System Medical Center, Moreno Valley, USA.

Department of Research, Alabama College of Osteopathic Medicine, Dothan, USA.

出版信息

Cureus. 2022 Mar 14;14(3):e23161. doi: 10.7759/cureus.23161. eCollection 2022 Mar.

DOI:10.7759/cureus.23161
PMID:35444882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9010001/
Abstract

Introduction Vasospasm is a significant cause of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (SAH). The purpose of this study is to evaluate a possible link between vasospasm in patients with aneurysmal SAH and magnesium and blood pressure levels. Methods Subjects were selected based on chart review of patients presenting to a comprehensive stroke center in Southern California with aneurysmal SAH. 27 were included based on the following criteria: patients greater than 18 years of age, aneurysmal SAH, clinically symptomatic vasospasms and at least one diagnostic confirmation - either from a transcranial doppler (TCD) or digital subtraction angiogram (DSA). The following exclusion criteria also applied: 1) incomplete documentation in the medical record; 2) patients <18 years of age; and 3) patients without TCD measurements. Results In an overall analysis of all patients with or without vasospasm, it was found that the presence of vasospasm was significantly correlated with diastolic blood pressures (DBPs) on day of vasospasm with an r value of 0.418 and p<0.001. Average daily DBPs throughout hospital stay were also correlated with vasospasm with an r-value of 0.455 and p<0.001. Changes in magnesium overall were also significantly related to left Lindegaard ratios with an r value of -0.201 and p value of 0.032. Lindegaard ratios were significantly correlated with age with r values of 0.510, p<0.001, and r=-0.482, p<0.001 for left and right, respectively. A change in magnesium was inversely correlated to the left Lindegaard ratio with an n of 31 and p value of 0.014 (r= -0.439) in patients with vasospasm. We also found a lower incidence of vasospasm in patients older than 65. Conclusion Monitoring magnesium and increases in DBP might be effective as a prophylactic adjunct method in patients with SAH in an effort to predict clinical vasospasm.

摘要

引言 血管痉挛是动脉瘤性蛛网膜下腔出血(SAH)患者发病和死亡的重要原因。本研究的目的是评估动脉瘤性SAH患者的血管痉挛与镁及血压水平之间可能存在的联系。方法 通过对南加州一家综合卒中中心收治的动脉瘤性SAH患者的病历进行回顾来选择研究对象。基于以下标准纳入了27例患者:年龄大于18岁、动脉瘤性SAH、临床上有症状的血管痉挛且至少有一项诊断确认——经颅多普勒(TCD)或数字减影血管造影(DSA)。以下排除标准也适用:1)病历记录不完整;2)年龄<18岁的患者;3)未进行TCD测量的患者。结果 在对所有有或无血管痉挛的患者进行的总体分析中,发现血管痉挛的存在与血管痉挛当天的舒张压(DBP)显著相关,r值为0.418,p<0.001。整个住院期间的平均每日DBP也与血管痉挛相关,r值为0.455,p<0.001。总体镁的变化也与左侧Lindegaard比值显著相关,r值为 -0.201,p值为0.032。Lindegaard比值与年龄显著相关,左侧和右侧的r值分别为0.510,p<0.001和r = -0.482,p<0.001。在有血管痉挛的患者中,镁的变化与左侧Lindegaard比值呈负相关,n为31,p值为0.014(r = -0.439)。我们还发现65岁以上患者的血管痉挛发生率较低。结论 监测镁和DBP升高可能作为SAH患者的一种预防性辅助方法有效,以预测临床血管痉挛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/039e/9010001/6482f16553a5/cureus-0014-00000023161-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/039e/9010001/6482f16553a5/cureus-0014-00000023161-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/039e/9010001/6482f16553a5/cureus-0014-00000023161-i01.jpg

相似文献

1
Magnesium Levels and Diastolic Blood Pressure (DBP) as a Vasospasm Prediction Metric in Patients With Aneurysmal Subarachnoid Hemorrhage (SAH).镁水平与舒张压(DBP)作为动脉瘤性蛛网膜下腔出血(SAH)患者血管痉挛预测指标的研究
Cureus. 2022 Mar 14;14(3):e23161. doi: 10.7759/cureus.23161. eCollection 2022 Mar.
2
Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.血管痉挛概率指数:经颅多普勒速度、脑血流量和临床风险因素的组合,用于预测动脉瘤性蛛网膜下腔出血后的脑血管痉挛。
J Neurosurg. 2007 Dec;107(6):1101-12. doi: 10.3171/JNS-07/12/1101.
3
Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.硫酸镁溶液持续脑池灌洗对动脉瘤性蛛网膜下腔出血相关脑血管造影血管痉挛的预防作用:一项随机对照试验。
J Neurosurg. 2016 Jan;124(1):18-26. doi: 10.3171/2015.1.JNS142757. Epub 2015 Jul 31.
4
Extent of collateralization predicting symptomatic cerebral vasospasm among pediatric patients: correlations among angiography, transcranial Doppler ultrasonography, and clinical findings.小儿患者中侧支循环程度对症状性脑血管痉挛的预测作用:血管造影、经颅多普勒超声及临床发现之间的相关性
J Neurosurg Pediatr. 2015 Mar;15(3):282-90. doi: 10.3171/2014.9.PEDS14313. Epub 2015 Jan 2.
5
Bedside monitoring of cerebral blood oxygenation and hemodynamics after aneurysmal subarachnoid hemorrhage by quantitative time-resolved near-infrared spectroscopy.定量时间分辨近红外光谱监测颅内出血后脑血氧和血流动力学变化。
World Neurosurg. 2010 May;73(5):508-13. doi: 10.1016/j.wneu.2010.02.061.
6
The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.持续静脉输注硫酸镁预防动脉瘤性蛛网膜下腔出血后脑血管痉挛的安全性和可行性。
Neurocrit Care. 2005;3(1):16-23. doi: 10.1385/NCC:3:1:016.
7
Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后的硫酸镁治疗
J Neurosurg. 2002 Mar;96(3):510-4. doi: 10.3171/jns.2002.96.3.0510.
8
Transcranial Doppler Sonography Defined Vasospasm, Ischemic Brain Lesions, and Delayed Ischemic Neurological Deficit in Younger and Elderly Patients after Aneurysmal Subarachnoid Hemorrhage.经颅多普勒超声定义的蛛网膜下腔出血后年轻和老年患者的血管痉挛、缺血性脑损伤和迟发性缺血性神经功能缺损。
World Neurosurg. 2020 Jun;138:e718-e724. doi: 10.1016/j.wneu.2020.03.051. Epub 2020 Mar 17.
9
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.莫西赛利预防蛛网膜下腔出血后血管痉挛相关的迟发性缺血性神经功能缺损和迟发性脑梗死及改善临床结局:一项单中心临床观察性研究
J Neurosurg. 2016 Jan;124(1):51-8. doi: 10.3171/2014.12.JNS13846. Epub 2015 Jul 10.
10
Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage.血清镁水平与动脉瘤性蛛网膜下腔出血后的症状性血管痉挛及预后的关系。
Neurocrit Care. 2004;1(4):441-8. doi: 10.1385/NCC:1:4:441.

本文引用的文献

1
Blood pressure changes after aneurysmal subarachnoid hemorrhage and their relationship to cerebral vasospasm and clinical outcome.动脉瘤性蛛网膜下腔出血后的血压变化及其与脑血管痉挛和临床结局的关系。
Clin Neurol Neurosurg. 2014 Oct;125:36-40. doi: 10.1016/j.clineuro.2014.06.023. Epub 2014 Jul 9.
2
Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?脑动脉痉挛预测、诊断及治疗中的当前争议:我们处于什么位置?
Neurol Res Int. 2013;2013:373458. doi: 10.1155/2013/373458. Epub 2013 Oct 8.
3
A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology.
颅内动脉瘤性蛛网膜下腔出血后迟发性缺血性神经功能缺损的研究进展:历史回顾、当前治疗和发病机制。
World Neurosurg. 2010 Jun;73(6):654-67. doi: 10.1016/j.wneu.2010.02.005.
4
Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.静脉硫酸镁治疗动脉瘤性蛛网膜下腔出血(IMASH):一项随机、双盲、安慰剂对照、多中心 III 期临床试验。
Stroke. 2010 May;41(5):921-6. doi: 10.1161/STROKEAHA.109.571125. Epub 2010 Apr 8.
5
Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.硫酸镁用于动脉瘤性蛛网膜下腔出血患者的治疗:一项随机、安慰剂对照、剂量适应性试验。
Surg Neurol. 2008 Jan;69(1):33-9; discussion 39. doi: 10.1016/j.surneu.2007.07.015.
6
Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.静脉注射镁剂与尼莫地平治疗动脉瘤性蛛网膜下腔出血患者的随机研究
Neurosurgery. 2006 Jun;58(6):1054-65; discussion 1054-65. doi: 10.1227/01.NEU.0000215868.40441.D9.
7
Medical complications after subarachnoid hemorrhage: new strategies for prevention and management.蛛网膜下腔出血后的医学并发症:预防与管理的新策略
Curr Opin Crit Care. 2006 Apr;12(2):78-84. doi: 10.1097/01.ccx.0000216571.80944.65.
8
Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity.硫酸镁:作为血管痉挛发病率可能的衰减因素的作用。
Surg Neurol. 2006;65 Suppl 1:S1:14-1:20; discussion S1:20-1:21. doi: 10.1016/j.surneu.2005.11.035.
9
Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review.动脉瘤性蛛网膜下腔出血患者脑血管痉挛的预测:综述
Neurosurgery. 2005 Apr;56(4):633-54; discussion 633-54. doi: 10.1227/01.neu.0000156644.45384.92.
10
Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage.镁:预防动脉瘤性蛛网膜下腔出血后脑血管痉挛的有用辅助药物。
J Clin Neurosci. 2002 May;9(3):279-81. doi: 10.1054/jocn.2001.1039.